vs
Side-by-side financial comparison of indie Semiconductor, Inc. (INDI) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
indie Semiconductor, Inc. is the larger business by last-quarter revenue ($55.5M vs $31.1M, roughly 1.8× LIFECORE BIOMEDICAL, INC. \DE\). On growth, indie Semiconductor, Inc. posted the faster year-over-year revenue change (2.6% vs -4.5%). Over the past eight quarters, indie Semiconductor, Inc.'s revenue compounded faster (2.9% CAGR vs -0.1%).
indie Semiconductor is a fabless semiconductor manufacturer focused on designing high-performance mixed-signal and embedded system-on-chip solutions for the automotive industry. Its products support advanced driver assistance systems, in-vehicle infotainment, connected car, and electric vehicle applications, serving global auto OEMs and tier 1 suppliers across major global markets.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
INDI vs LFCR — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $55.5M | $31.1M |
| Net Profit | — | $-10.0M |
| Gross Margin | 38.0% | 25.0% |
| Operating Margin | -70.1% | -9.9% |
| Net Margin | — | -32.1% |
| Revenue YoY | 2.6% | -4.5% |
| Net Profit YoY | — | -52.0% |
| EPS (diluted) | — | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $55.5M | — | ||
| Q4 25 | $58.0M | — | ||
| Q3 25 | $53.7M | $31.1M | ||
| Q2 25 | $51.6M | — | ||
| Q1 25 | $54.1M | $35.2M | ||
| Q4 24 | $58.0M | $32.6M | ||
| Q3 24 | $54.0M | $24.7M | ||
| Q2 24 | $52.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | $-31.2M | — | ||
| Q3 25 | $-38.3M | $-10.0M | ||
| Q2 25 | $-39.0M | — | ||
| Q1 25 | $-34.5M | $-14.8M | ||
| Q4 24 | $-34.4M | $-6.6M | ||
| Q3 24 | $-49.7M | $-16.2M | ||
| Q2 24 | $-19.2M | — |
| Q1 26 | 38.0% | — | ||
| Q4 25 | 37.3% | — | ||
| Q3 25 | 40.1% | 25.0% | ||
| Q2 25 | 40.6% | — | ||
| Q1 25 | 41.7% | 28.0% | ||
| Q4 24 | 42.6% | 34.0% | ||
| Q3 24 | 39.3% | 21.8% | ||
| Q2 24 | 42.2% | — |
| Q1 26 | -70.1% | — | ||
| Q4 25 | -58.5% | — | ||
| Q3 25 | -71.4% | -9.9% | ||
| Q2 25 | -83.3% | — | ||
| Q1 25 | -72.0% | -25.7% | ||
| Q4 24 | -58.4% | -6.0% | ||
| Q3 24 | -92.5% | -46.9% | ||
| Q2 24 | -70.0% | — |
| Q1 26 | — | — | ||
| Q4 25 | -53.8% | — | ||
| Q3 25 | -71.3% | -32.1% | ||
| Q2 25 | -75.6% | — | ||
| Q1 25 | -63.9% | -42.0% | ||
| Q4 24 | -59.2% | -20.2% | ||
| Q3 24 | -92.1% | -65.7% | ||
| Q2 24 | -36.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | $-0.16 | — | ||
| Q3 25 | $-0.19 | $-0.29 | ||
| Q2 25 | $-0.20 | — | ||
| Q1 25 | $-0.18 | $-0.47 | ||
| Q4 24 | $-0.18 | $-0.25 | ||
| Q3 24 | $-0.28 | $-0.53 | ||
| Q2 24 | $-0.11 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $174.4M | $18.9M |
| Total DebtLower is stronger | $402.8M | $136.0M |
| Stockholders' EquityBook value | $348.9M | $-10.5M |
| Total Assets | $869.6M | $235.2M |
| Debt / EquityLower = less leverage | 1.15× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $174.4M | — | ||
| Q4 25 | $145.5M | — | ||
| Q3 25 | $160.9M | $18.9M | ||
| Q2 25 | $192.6M | — | ||
| Q1 25 | $236.6M | $5.4M | ||
| Q4 24 | $274.2M | $9.5M | ||
| Q3 24 | $96.9M | — | ||
| Q2 24 | $112.3M | — |
| Q1 26 | $402.8M | — | ||
| Q4 25 | $353.4M | — | ||
| Q3 25 | $353.5M | $136.0M | ||
| Q2 25 | $352.5M | — | ||
| Q1 25 | $379.0M | $124.9M | ||
| Q4 24 | $381.3M | $111.3M | ||
| Q3 24 | — | $106.3M | ||
| Q2 24 | — | — |
| Q1 26 | $348.9M | — | ||
| Q4 25 | $358.0M | — | ||
| Q3 25 | $369.2M | $-10.5M | ||
| Q2 25 | $390.4M | — | ||
| Q1 25 | $405.6M | $2.2M | ||
| Q4 24 | $417.9M | $15.4M | ||
| Q3 24 | $458.6M | $-3.9M | ||
| Q2 24 | $470.7M | — |
| Q1 26 | $869.6M | — | ||
| Q4 25 | $840.8M | — | ||
| Q3 25 | $855.1M | $235.2M | ||
| Q2 25 | $867.6M | — | ||
| Q1 25 | $909.0M | $237.7M | ||
| Q4 24 | $941.4M | $255.4M | ||
| Q3 24 | $797.5M | $246.8M | ||
| Q2 24 | $797.3M | — |
| Q1 26 | 1.15× | — | ||
| Q4 25 | 0.99× | — | ||
| Q3 25 | 0.96× | — | ||
| Q2 25 | 0.90× | — | ||
| Q1 25 | 0.93× | 56.05× | ||
| Q4 24 | 0.91× | 7.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $1.8M |
| Free Cash FlowOCF − Capex | — | $25.0K |
| FCF MarginFCF / Revenue | — | 0.1% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-14.4M | — | ||
| Q3 25 | $-6.2M | $1.8M | ||
| Q2 25 | $-7.6M | — | ||
| Q1 25 | $-29.0M | $1.2M | ||
| Q4 24 | $-6.7M | $-6.1M | ||
| Q3 24 | $-22.8M | $-613.0K | ||
| Q2 24 | $-19.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | $-16.1M | — | ||
| Q3 25 | $-10.3M | $25.0K | ||
| Q2 25 | $-13.6M | — | ||
| Q1 25 | $-31.4M | $-4.3M | ||
| Q4 24 | $-8.6M | $-8.6M | ||
| Q3 24 | $-29.3M | $-4.0M | ||
| Q2 24 | $-23.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | -27.8% | — | ||
| Q3 25 | -19.2% | 0.1% | ||
| Q2 25 | -26.4% | — | ||
| Q1 25 | -58.0% | -12.1% | ||
| Q4 24 | -14.8% | -26.3% | ||
| Q3 24 | -54.3% | -16.3% | ||
| Q2 24 | -44.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.0% | — | ||
| Q3 25 | 7.8% | 5.6% | ||
| Q2 25 | 11.6% | — | ||
| Q1 25 | 4.4% | 15.5% | ||
| Q4 24 | 3.2% | 7.5% | ||
| Q3 24 | 12.1% | 13.9% | ||
| Q2 24 | 7.0% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
INDI
| Product revenue | $51.6M | 93% |
| Contract revenue | $3.9M | 7% |
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
